Skip to main content
. 2021 Sep 6;12(19):2564–2573. doi: 10.1111/1759-7714.14137

FIGURE 1.

FIGURE 1

Flow diagram of the specimen included in the study. NSCLC, non‐small cell lung cancer; ICI, immune checkpoint inhibitor; NGS, next‐generation sequencing; FFPE, formalin‐fixed paraffin‐embedded; IHC, immunohistochemistry; pSHP2, phospho‐SHP2; PD‐L1, programmed death ligand 1; PFS, progression‐free survival; OS, overall survival; mIFC, multiplexed immunofluorescence cytochemistry